Literature DB >> 3169137

The membrane transport system responsible for multidrug resistance is operating in nonresistant cells.

A A Neyfakh1, T V Dmitrevskaya, A S Serpinskaya.   

Abstract

Cultured hamster fibroblasts of the DM-15 cell line stained by rhodamine 123 gradually release the dye when placed in dye-free medium. Here we demonstrate that reserpine, verapamil, and trifluoperazine are capable of blocking this release. We also show that reserpine can inhibit the efflux of another dye, phosphine 3R, from DM-15 cells and the release of rhodamine 123 from mouse embryo fibroblasts, four mouse cell lines, and MDCK cells. The three substances that block the release of the dyes are potent inhibitors of the membrane transport system implicated in the phenomenon of multidrug resistance (MDR). By using this system MDR cells can pump many structurally unrelated drugs and dyes, including rhodamine 123 and phosphine 3R, from the cytoplasm to the outer medium. It appears from our results that the membrane transport system responsible for MDR operates slowly in nonresistant cells and can play a role in normal cell physiology.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3169137     DOI: 10.1016/0014-4827(88)90419-3

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  4 in total

1.  P-glycoprotein and alloimmune T-cell activation.

Authors:  Shona S Pendse; David M Briscoe; Markus H Frank
Journal:  Clin Appl Immunol Rev       Date:  2003-07

2.  Novobiocin modulates colchicine sensitivity in parental and multidrug-resistant B16 melanoma cells.

Authors:  J Nordenberg; J Kornfeld; L Wasserman; M Shafran; E Halabe; E Beery; O Landau; A Novogrodsky; Y Sidi
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

3.  Assessment of P-glycoprotein-dependent drug transport in isolated rat hepatocytes using rhodamine 123.

Authors:  E Chieli; E Santoni Rugiu; F Cervelli; A Paolicchi; R Tongiani
Journal:  Cell Biol Toxicol       Date:  1993 Jul-Sep       Impact factor: 6.691

4.  Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.

Authors:  Augusto Pessina; Arianna Bonomi; Valentina Coccè; Gloria Invernici; Stefania Navone; Loredana Cavicchini; Francesca Sisto; Maura Ferrari; Lucia Viganò; Alberta Locatelli; Emilio Ciusani; Graziella Cappelletti; Daniele Cartelli; Caruso Arnaldo; Eugenio Parati; Giovanni Marfia; Roberto Pallini; Maria Laura Falchetti; Giulio Alessandri
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.